Literature DB >> 24468652

Mouse models of cancer: Sleeping Beauty transposons for insertional mutagenesis screens and reverse genetic studies.

Barbara R Tschida1, David A Largaespada1, Vincent W Keng2.   

Abstract

The genetic complexity and heterogeneity of cancer has posed a problem in designing rationally targeted therapies effective in a large proportion of human cancer. Genomic characterization of many cancer types has provided a staggering amount of data that needs to be interpreted to further our understanding of this disease. Forward genetic screening in mice using Sleeping Beauty (SB) based insertional mutagenesis is an effective method for candidate cancer gene discovery that can aid in distinguishing driver from passenger mutations in human cancer. This system has been adapted for unbiased screens to identify drivers of multiple cancer types. These screens have already identified hundreds of candidate cancer-promoting mutations. These can be used to develop new mouse models for further study, which may prove useful for therapeutic testing. SB technology may also hold the key for rapid generation of reverse genetic mouse models of cancer, and has already been used to model glioblastoma and liver cancer.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cancer gene discovery; Insertional mutagenesis; Mouse models; Sleeping Beauty; Transposable elements

Mesh:

Substances:

Year:  2014        PMID: 24468652      PMCID: PMC4035448          DOI: 10.1016/j.semcdb.2014.01.006

Source DB:  PubMed          Journal:  Semin Cell Dev Biol        ISSN: 1084-9521            Impact factor:   7.727


  80 in total

1.  Combinatorial antiangiogenic gene therapy by nonviral gene transfer using the sleeping beauty transposon causes tumor regression and improves survival in mice bearing intracranial human glioblastoma.

Authors:  John R Ohlfest; Zachary L Demorest; Yasuhiko Motooka; Isabelita Vengco; Seunguk Oh; Eleanor Chen; Frank A Scappaticci; Rachel J Saplis; Stephen C Ekker; Walter C Low; Andrew B Freese; David A Largaespada
Journal:  Mol Ther       Date:  2005-09-16       Impact factor: 11.454

2.  Molecular reconstruction of Sleeping Beauty, a Tc1-like transposon from fish, and its transposition in human cells.

Authors:  Z Ivics; P B Hackett; R H Plasterk; Z Izsvák
Journal:  Cell       Date:  1997-11-14       Impact factor: 41.582

3.  Transposition and gene disruption in the male germline of the mouse.

Authors:  A J Dupuy; S Fritz; D A Largaespada
Journal:  Genesis       Date:  2001-06       Impact factor: 2.487

4.  Cancer gene discovery in solid tumours using transposon-based somatic mutagenesis in the mouse.

Authors:  Lara S Collier; Corey M Carlson; Shruthi Ravimohan; Adam J Dupuy; David A Largaespada
Journal:  Nature       Date:  2005-07-14       Impact factor: 49.962

5.  Cell of origin strongly influences genetic selection in a mouse model of T-ALL.

Authors:  Katherine E Berquam-Vrieze; Kishore Nannapaneni; Benjamin T Brett; Linda Holmfeldt; Jing Ma; Oksana Zagorodna; Nancy A Jenkins; Neal G Copeland; David K Meyerholz; C Michael Knudson; Charles G Mullighan; Todd E Scheetz; Adam J Dupuy
Journal:  Blood       Date:  2011-08-09       Impact factor: 22.113

Review 6.  Genetic modeling of gliomas in mice: new tools to tackle old problems.

Authors:  Dolores Hambardzumyan; Luis F Parada; Eric C Holland; Al Charest
Journal:  Glia       Date:  2011-02-08       Impact factor: 7.452

Review 7.  WNT and beta-catenin signalling: diseases and therapies.

Authors:  Randall T Moon; Aimee D Kohn; Giancarlo V De Ferrari; Ajamete Kaykas
Journal:  Nat Rev Genet       Date:  2004-09       Impact factor: 53.242

8.  Insertional mutagenesis identifies multiple networks of cooperating genes driving intestinal tumorigenesis.

Authors:  H Nikki March; Alistair G Rust; Nicholas A Wright; Jelle ten Hoeve; Jeroen de Ridder; Matthew Eldridge; Louise van der Weyden; Anton Berns; Jules Gadiot; Anthony Uren; Richard Kemp; Mark J Arends; Lodewyk F A Wessels; Douglas J Winton; David J Adams
Journal:  Nat Genet       Date:  2011-11-06       Impact factor: 38.330

9.  The deubiquitinase USP9X suppresses pancreatic ductal adenocarcinoma.

Authors:  Pedro A Pérez-Mancera; Alistair G Rust; Louise van der Weyden; Glen Kristiansen; Allen Li; Aaron L Sarver; Kevin A T Silverstein; Robert Grützmann; Daniela Aust; Petra Rümmele; Thomas Knösel; Colin Herd; Derek L Stemple; Ross Kettleborough; Jacqueline A Brosnan; Ang Li; Richard Morgan; Spencer Knight; Jun Yu; Shane Stegeman; Lara S Collier; Jelle J ten Hoeve; Jeroen de Ridder; Alison P Klein; Michael Goggins; Ralph H Hruban; David K Chang; Andrew V Biankin; Sean M Grimmond; Lodewyk F A Wessels; Stephen A Wood; Christine A Iacobuzio-Donahue; Christian Pilarsky; David A Largaespada; David J Adams; David A Tuveson
Journal:  Nature       Date:  2012-04-29       Impact factor: 49.962

Review 10.  The Sleeping Beauty transposable element: evolution, regulation and genetic applications.

Authors:  Zoltán Ivics; Christopher D Kaufman; Hatem Zayed; Csaba Miskey; Oliver Walisko; Zsuzsanna Izsvák
Journal:  Curr Issues Mol Biol       Date:  2004-01       Impact factor: 2.081

View more
  8 in total

Review 1.  Engineered Swine Models of Cancer.

Authors:  Adrienne L Watson; Daniel F Carlson; David A Largaespada; Perry B Hackett; Scott C Fahrenkrug
Journal:  Front Genet       Date:  2016-05-09       Impact factor: 4.599

2.  SRC-2-mediated coactivation of anti-tumorigenic target genes suppresses MYC-induced liver cancer.

Authors:  Shruthy Suresh; Deniz Durakoglugil; Xiaorong Zhou; Bokai Zhu; Sarah A Comerford; Chao Xing; Xian-Jin Xie; Brian York; Kathryn A O'Donnell
Journal:  PLoS Genet       Date:  2017-03-08       Impact factor: 5.917

3.  Rapid tumor induction in zebrafish by TALEN-mediated somatic inactivation of the retinoblastoma1 tumor suppressor rb1.

Authors:  Staci L Solin; Heather R Shive; Kevin D Woolard; Jeffrey J Essner; Maura McGrail
Journal:  Sci Rep       Date:  2015-09-08       Impact factor: 4.379

4.  Mulberry fruit prevents LPS-induced NF-κB/pERK/MAPK signals in macrophages and suppresses acute colitis and colorectal tumorigenesis in mice.

Authors:  Zhengjiang Qian; Zhiqin Wu; Lian Huang; Huiling Qiu; Liyan Wang; Li Li; Lijun Yao; Kang Kang; Junle Qu; Yonghou Wu; Jun Luo; Johnson J Liu; Yi Yang; Wancai Yang; Deming Gou
Journal:  Sci Rep       Date:  2015-11-30       Impact factor: 4.379

Review 5.  White paper on microbial anti-cancer therapy and prevention.

Authors:  Neil S Forbes; Robert S Coffin; Liang Deng; Laura Evgin; Steve Fiering; Matthew Giacalone; Claudia Gravekamp; James L Gulley; Hal Gunn; Robert M Hoffman; Balveen Kaur; Ke Liu; Herbert Kim Lyerly; Ariel E Marciscano; Eddie Moradian; Sheryl Ruppel; Daniel A Saltzman; Peter J Tattersall; Steve Thorne; Richard G Vile; Halle Huihong Zhang; Shibin Zhou; Grant McFadden
Journal:  J Immunother Cancer       Date:  2018-08-06       Impact factor: 13.751

Review 6.  Transgenic Mouse Models in Cancer Research.

Authors:  Ursa Lampreht Tratar; Simon Horvat; Maja Cemazar
Journal:  Front Oncol       Date:  2018-07-20       Impact factor: 6.244

7.  Changes in Skeletal Muscle and Body Weight on Sleeping Beauty Transposon-Mediated Transgenic Mice Overexpressing Pig mIGF-1.

Authors:  Bo Gao; Wei Wang; Han Wu; Cai Chen; Dan Shen; Saisai Wang; Wei Chen; Li Zhang; Shuheng Chan; Chengyi Song
Journal:  Biochem Genet       Date:  2018-02-22       Impact factor: 1.890

8.  Novel, genetically induced mouse model that recapitulates the histological morphology and immunosuppressive tumor microenvironment of metastatic peritoneal carcinomatosis.

Authors:  Deyin Xing; Chien-Fu Hung; Ssu-Hsueh Tseng; Sung-Taek Park; Brandon Lam; Ya-Chea Tsai; Max A Cheng; Emily Farmer
Journal:  J Immunother Cancer       Date:  2020-02       Impact factor: 13.751

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.